IRTC Q3 2024 Earnings — iRhythm Technologies, Inc. Revenue & Financial Results | Market Cap Arena

IRTCiRhythm Technologies, Inc.

$4B

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$148M+18.4% YoY

Gross Profit

$101M68.8% margin

Operating Income

-$50M-34.1% margin

Net Income

-$46M-31.3% margin

EPS (Diluted)

$-1.48

QoQ Revenue Growth

-0.3%

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

$16M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$910M

Total Liabilities

$838M

Stockholders' Equity

$72M

Cash & Equivalents

$520M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$148M	$125M	+18.4%
Gross Profit	$101M	$82M	+23.0%
Operating Income	-$50M	-$28M	-82.2%
Net Income	-$46M	-$27M	-70.3%

Revenue Segments

Commercial Payors

$77M52%

Centers For Medicare And Medicaid

$36M24%

Healthcare Institutions

$23M16%

Non-Contracted Third-Party Payors

$11M7%